Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Role of Benign Joint Hypermobility in Functional Pain Disorders

Lara C. Pullen, PhD  |  October 3, 2016

shutterstock_HipBone_500x270Physicians diagnose benign joint hypermobility (BJH) syndrome in individuals with musculoskeletal symptoms who also have excessive joint laxity. In particular, adolescents with functional gastrointestinal (GI) disorders are often also diagnosed with joint hypermobility, as well as fibromyalgia. This finding has led some experts to suggest that functional GI disorders and BJH may share an underlying pathophysiology. Therefore, they recommend that individuals with complex functional GI disorders should be screened for joint hypermobility and fibromyalgia, as well as co-morbid symptoms, such as sleep disturbances, migraines and autonomic dysfunction.1 Thus far, however, studies into the role of autonomic dysfunction in BJH have suggested that although postural orthostatic tachycardia syndrome (POTS) is common in adolescents with functional GI disorders, it’s not common in children with hypermobility. These findings have left physicians puzzled as to the relationship between joint hypermobility and autonomic dysfunction.

Recently, researchers have tried to dig deeper into the unresolved issue of the role of BJH in the development of autonomic symptoms and comorbidities. To answer this question, Gisela Chelimsky, MD, from the Medical College of Wisconsin in Milwaukee, and colleagues compared children with chronic functional pain disorders and BJH with a similar cohort of patients with chronic functional pain disorders in the absence of BJH. The direct comparison allowed the investigators to determine if patients with BJH have more autonomic dysfunction than patients who present with similar complaints but do not have BJH. The retrospective chart review included a total of 21 female patients seen in a pediatric neurogastroenterology and autonomic clinic. Eleven of the subjects had BJH, as confirmed by genetics consultation and/or meeting the classic Brighton criteria. The authors note that, in general, patients who are referred to this clinic have a variety of autonomic complaints, migraines, nausea and fatigue, as well as functional GI disorders.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Both groups had a similar age of symptom onset: 15.6 years for those with BJH and 15.4 years for those without BJH. Most of the children in both groups presented with migraine or GI complaints as their chronic functional pain. Other complaints included chronic fatigue, lightheadedness, dizziness, fainting more than three times in their lifetimes and delayed onset of sleep. None of the patients had fibromyalgia as diagnosed by greater than 10 tender points. All told, the total number of co-morbid symptoms did not differ between the two groups.

The investigators evaluated the patients for tilt-table diagnoses of POTS, syncope, orthostatic intolerance symptoms that did not meet the criteria of POTS, orthostatic hypotension, baseline heart rate, peak heart rate in first 10 minutes of head-up tilt and sudomotor index. They then quantified the autonomic testing results using a composite autonomic severity score. The researchers found that neither the individual measurements nor the composite autonomic severity score differed between the two cohorts.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsSoft Tissue Pain Tagged with:benign joint hypermobilitycomorbiditiesFibromialgiagastrointestinaljointPain

Related Articles

    Strides in Recognition and Management of Joint Hypermobility Syndrome

    May 1, 2010

    Strides in recognition and management of joint hypermobility syndrome

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Chronic Fatigue Syndrome: Are There Different Phenotypes?

    December 18, 2017

    New research has examined the autonomic parameters of patients with chronic fatigue syndrome (CFS) using the DePaul Symptom Questionnaire to place patients on a disease spectrum. Researchers found different groups of CFS patients had different levels of autonomic dysfunction and cognitive impairment, suggesting that different CFS criteria may diagnose a spectrum of disease severities and different CFS phenotypes…

    Is Fibromyalgia Overdiagnosed?

    October 10, 2016

    Are too many patients diagnosed with fibromyalgia? The co-authors of one new study believe that close to 75% of patients who have received a clinical fibromyalgia diagnosis do not meet the 2010 Preliminary American College of Rheumatology (ACR) Criteria for Fibromyalgia.1 They say these patients are false-positive and may be taking treatments they don’t need….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences